<DOC>
	<DOCNO>NCT00827788</DOCNO>
	<brief_summary>The purpose study determine incidence contrast induce nephropathy myocardial tissue reperfusion follow iso-osmolar iodixanol ipo-osmolar iopromide administration patient acute myocardial infarction undergo primary PCI .</brief_summary>
	<brief_title>Comparison Between Iso-Osmolar Ipo-Osmolar Contrast Agents Patients With Acute Myocardial Infarction ( AMI ) Undergoing Primary Percutaneous Coronary Intervention ( PCI )</brief_title>
	<detailed_description>This multicentric randomized comparison iso-osmolar ipo-osmolar contrast agent patient treat primary PCI evaluation contrast-induced nephropathy incidence myocardial tissue reperfusion . The study design non-inferiority trial .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Men woman age â‰¥ 18 Patients STelevation Myocardial Infarction present within 12 hour onset symptom ( 18 hour case cardiogenic shock ) , schedule undergo primary PCI Patients sign date write informed consent form Patients pregnancy lactation Longterm dialysis Administration investigational drug within previous 30 day Intraarterial intravenous administration iodinate contrast medium 7 day 72 hour administration study drug Intake nephrotoxic medication 24 hour administration study drug Contraindications study drug cardiac catheterization procedure Previous participation study As discretion investigator , patient condition appropriate usage iodinate contrast agent appropriate undergo cardiac catheterization procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>contrast medium</keyword>
	<keyword>angiography</keyword>
	<keyword>percutaneous coronary intervention</keyword>
</DOC>